Abstract-Diadenosine tetraphosphate (AP4A) belongs to a wide group of naturally derived endogenous purine compounds that have recently been considered as new neurotransmitters in the autonomic nervous system. It has been shown that AP4A induces inhibitory effects and modulates adrenergic control in the heart of adult mammals. Nevertheless, the physiological significance of AP4A in early postnatal development, when sympathetic innervation remains yet immature, has not been investigated. The aim of the present study was to elucidate the effects of AP4A on the heart bioelectrical activity in early postnatal ontogenesis. Action potentials (AP) were recorded using the standard microelectrode technique in multicellular isolated right atrial (RA), left atrial (LA), and ventricle (RV) preparations from male Wistar rats at postnatal days 1, 14, and 21 and from 60-day animals that were considered as adults. The application of AP4A caused significant reduction of AP duration in atrial (RA and LA) preparations from rats of all ages. Also, AP4A caused significant AP shortening in RV preparations from rats of various ages; however, the effect was more pronounced in 21-day-old and adult rats. AP4A failed to alter automaticity of RA preparations from the rats at postnatal days 1, 14, and 21 and weakly decreased spontaneous rhythm in RA preparations from the adult rats. The effect of AP4A was partially abolished by P2-receptor blocker PPADS in LA preparations from both 21-dayold and adult rats, while it failed to suppress AP4A-caused AP shortening in preparations from 1-and 14-dayold animals. Thus, extracellular AP4A causes shortening of AP both in the atrial and ventricular myocardium in the rats of early postnatal ontogenesis and in adults. The effect of AP4A depends on age only for ventricular myocardium where it may be attributed with growing contribution of diadenosine polyphosphates to the control of myocardium inotropy.
INTRODUCTION
Diadenosine polyphosphates (APnA) belong to a wide group of purine compounds, the molecule of which includes two adenosines connected by a chain of 2-7 residues of phosphoric acid. For the last decade, APnA have been considered as endogenous signaling compounds that are present in a variety of tissues and are involved in the regulation of a number of physiological functions [1] .
It is shown that extracellular APnA affect the functioning of the heart of adult animals: they suppress its contractile activity and cause a change in the action potentials and ion currents [2] [3] [4] [5] . Since APnA are purine compounds, their regulatory effects in the myocardium are associated with the action on the membrane receptors of purine nucleotides [6] [7] [8] . It is known that there are metabotropic P2Y-type receptors in the heart of mammals, including rats. Previously, in our and other studies, it has been shown that APnA cause a decrease in myocardial contractility by activating the P2Y-type receptors [9] .
The presence of P2Y-type receptors in the heart is found in both adult animals and in animals at the early stages of postnatal development [10] . It is also shown that sensitivity to extracellular purine nucleotides, caused by their membrane receptors, already appears at the early stages of embryogenesis [11] . However, the number and ratio of different subtypes of P2Y-receptors in the heart vary substantially during individual development [12] . The results of previous studies suggest that the effect of purine compounds on the cardiac function varies at different stages of ontogeny. Nevertheless, ontogenetic aspects of the effects and mechanisms of action of purine compounds have not been studied enough. What are the effects of APnA in the heart at early ontogeny also remains unknown.
According to the modern ideas, the regulatory influence of purines in the heart and other tissues largely lies in the regulation of sympathetic and parasympathetic influences [13] . It is shown that APnA exhibit neurotransmitter properties in the autonomic nervous system, and their main role in the heart can be reduced to the limitation of adrenergic effects [3, 14] .
The formation of vegetative control of the cardiac function occurs during postnatal ontogenesis. At present, it is not known whether APnA can affect cardiac function at the earliest stages of development, when sympathetic neuromuscular control is still lacking, and also during the critical stage of postnatal development that corresponds to the maturation of the sympathetic part of the autonomic nervous system. In rats, the formation of sympathetic control of the cardiac function occurs at the second to third week of individual development. Thus, we find it most interesting to study the effect of APnA for the cardiac function during that period of ontogeny that for the rat corresponds to the time interval from the first day after birth to the end of the third week of postnatal life.
It has now been shown that APnA, a chain of phosphoric acid residues that varies from two to six, are physiologically active. Among all APnA, diadenosine tetraphosphate (AP4A) has an average chain length of phosphoric acid residues among the others. For the first time, the physiological activity was detected particularly in AP4A. In addition, AP4A causes similar effects in the heart of several types of laboratory animals. As a result, AP4A was selected as the test compound in this research.
MATERIALS AND METHODS
The work was performed using rat heart preparations. A total of 89 preparations were obtained from 89 animals. During the experiments, all the current requirements of ethical standards for working with laboratory animals were fulfilled (European Convention on the Protection of Vertebrates Used for Experimental and Other Scientific Purposes, Strasbourg, 1986). Sexually mature males and females of Wistar rats (250-300 g, 10-week age) were obtained from the Scientific Center for Biomedical Technologies of the Federal Medical Biological Agency and used to obtain offspring. The animals were kept in a vivarium under standard conditions with a light mode of 12 : 12 with access to water and food ad libitum.
Heart preparations obtained from the rats at the end of the first day of postnatal development (D1) and on the 14 th , 21 st , and 60 th day (D14, D21, D60) of postnatal life were used in the experiments. Up to the 21 st day of life, the offspring was kept with females in individual cells and the rats were taken from seven litters evenly, which allowed receiving the animals of similar body mass in each age group. Rats aged 60 days were considered adults.
The action potentials (AP) in isolated multicellular perfused preparations of the right atrium, the left atrium, and the right ventricular wall of the rat were recorded to determine the effect of AP4A (SigmaAldrich, United States) on the bioelectrical activity of the heart using a standard microelectrode technique according to the procedure described in detail earlier [9] .
Before the experiment, the rats were decapitated, the chest was opened, the heart was extracted, and multicellular preparations were isolated. The preparations were placed in an experimental chamber and perfused at 37°C with oxygenated (O 2 95%, CO 2 5%) Tyrode solution (NaCl 129 mM, KCl 4 mM, NaH 2 PO 4 20.9 mM, MgSO 4 0.5 mM, NaHCO 3 20 mM, CaCl 2 1.2 mM, glucose 5 mM, pH 7.2-7.4) with a flow rate of 10 mL/min. In all multicellular preparations, with the exception of right atrial preparations, the action potentials were caused by applying electrical stimuli by silver electrodes connected to the ELS-2 stimulator (the stimulation frequency was 3.3 Hz, the duration of rectangular pulses was 2 ms, the pulse amplitude was 3-10 V).
APs were taken from the endocardial side of multicellular preparations. Glass microelectrodes (resistance of 10-30 MΩ) connected to a Model 1600 Headstage amplifier (A-M Systems, United States) were used for AP recording. The amplified signal was transmitted to the AD-converter E-154 (L-Card, Russia) and then processed on a computer using the Power Graph 3.3 program (Di-soft, Russia). In all experiments, the duration of AP was estimated at 50 and 90% repolarization (DAP50%, DAP90%) using MiniAnalysis 6.0.7. (Synaptosoft, United States). Since right atrial preparations included a pacemaker region and were able to generate AP spontaneously and rhythmically, the AP frequency was also assessed in this case.
After 30-min adaptation of multicellular preparations, a recording was made in the perfusion chamber; the recording consisted of two parts: recording the AP in the control conditions for 1 min; recording of AP by the action of AP4A at a concentration of 10 μM or with the simultaneous action of AP4A at a concentration of 10 μM and pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS, Sigma-Aldrich, United States) at a concentration of 100 μM for 10 min.
It should be noted that the duration of AP in the control conditions varied significantly in different parts of the heart and also significantly changed with age ( Fig. 1) . The greatest duration of AP in our experiments was observed in preparations obtained from animals at the end of the first day of postnatal life. Therefore, the duration of AP observed under the action of AP4A was expressed as a percentage of the control value for a particular preparation obtained from an animal of a particular age. Statistica 6.0 (StatSoft Inc., United States) was used for statistical processing of the results. Statistically significant differences between the groups were detected using the ANOVA test (followed by the use of tests for multiple comparisons in groups with repeated or independent post-hoc measurements, and subsequent Dunnett's test) after preliminary testing of the normality of distribution in groups using the ShapiroWilk test. Differences were considered significant at p < 0.05. The data are presented as the mean ± standard error of the mean (with the exception of the figures with AP examples).
RESULTS AND DISCUSSION
Previous studies have shown that the effects of purine compounds can change significantly during postnatal development. In this case, the nature of the reaction to purine nucleotides can change. It is well known that adenosine is an endogenous agonist of purine receptors of the P1-type, which include the A1-and A2-subtype receptors. In adult rats, adenosine causes a positive inotropic effect in the ventricular myocardium, activating the purine receptors of the A2-subtype, and the effect level increases as the animals grow. However, in the first weeks after birth, adenosine causes a negative inotropic effect in the rat heart due to activation of purine receptors of the A1-subtype, the number of which, respectively, decreases during postnatal development. Accordingly, in the rat heart at the first weeks of life, the antiadrenergic effect of purine compounds is higher than in adult animals due to the activation of A1-subtype receptors [14] [15] [16] . Effects in the heart associated with the action of P2-type receptor agonists, and, respectively, activation of P2-receptors, vary also in animals of different ages. Thus, the endogenous P2-type ATP receptor agonist has the strongest effect on contractility in the ventricular and atrial myocardium of the rat at the 21 st day of postnatal development [17, 18] . Therefore, the data of previous studies suggested that AP4A, as a physiologically active substance belonging to the group of purine compounds, can have a different effect on heart function in rats of different ages.
In our experiments, AP4A at a concentration of 10 μM significantly influenced AP in all the studied parts of the heart at different stages of postnatal development; this is shown for the first time. Representative examples of AP in control conditions, as well as in the action of AP4A in different cardiac preparations for different age groups, are shown in Figs. 1a and 1b . Under the action of AP4A, DAP90% in the left atrium was 75 ± 2%, 71 ± 3%, and 70 ± 5% in preparations obtained from animals at the end of the first day after birth, and on the 14 th and 21 st days of postnatal life, respectively, compared to that observed under control conditions. In the left atrium obtained from animals at the 60 th day of life, DAP90% under the action of AP4A was 77 ± 2% of the control value. In the right atrium, DAP90% decreased down to 79 ± 4%, 83 ± 3%, 80 ± 
3%
, and 78 ± 5% for the first, 14 th , 21 st , and 60 th day of postnatal life, respectively, compared to that observed under the control conditions. In all groups, the described effect of AP4A on DAP90% was statistically significant (p < 0.05, n = 6). In the ventricular myocardium, AP4A at a concentration of 10 μM caused a statistically significant (p < 0.05, n = 6) decrease in DAP90% to 83 ± 3% and 80 ± 3% in preparations obtained from animals at the end of the first day and on the 14 th day of life compared to that under control conditions. In the preparations of the ventricular myocardium on the 21 st and 60 th days of postnatal life, the effect of AP4A was also statistically significant. In addition, this effect was significantly greater (p < 0.05, n = 6) than that observed on the first and 14 th days of life: DAP90% decreased down to 72 ± 4% and 72 ± 4% of the control values, respectively (Figs. 2a -2c ).
AP4A caused a decrease in the duration of the AP at the level of 50% repolarization. The effect of AP4A on DAP50% and DAP90% did not differ significantly in any preparations obtained from animals of all ages except for the effect on AP duration in the right atrium of the animals at the 60 th day of postnatal development ( Fig. 2) . In this particular case, a 50% reduction in DAP caused by AP4A was much more than a reduction in DAP90% (p < 0.05, n = 6).
Therefore, these results allow us to state that AP4A causes a decrease in the duration of AP, the parameter that largely determines the inotropic state of the myocardium. AP4A reduces the duration of AP not only in the heart of adult rats (on the 60 th day of life) but also in the heart of animals in early postnatal ontogenesis (from the end of the first day after birth until the 21 st day of postnatal life). The magnitude of the effect of AP4A (shortening of AP) in the atrial myocardium is similar in the animals of all age groups studied. In contrast to the pattern observed for the atrial myocardium, the effect of AP4A in the ventricular myocardium was greater on the 21 st and 60 th days than on the first and 14 th days of life. This feature of the action of AP4A is typical for the duration of the AP as at both levels of repolarization, DAP50% and DAP90%. This fact may indicate that AP4A plays a more significant role as a neurotransmitter or a paracrine factor specif- ically in the ventricular myocardium when sympathetic control of the heart has been formed. Under control conditions, the rhythm generated by the pacemaker in the preparations of the right atrium was different. For preparations obtained from animals at the end of the first day after birth, the rhythm was 4.44 ± 0.4 Hz; those from animals on the 14 th and 21 st days of life were 4.49 ± 0.3 and 5.11 ± 0.3 Hz, respectively (Fig. 2d) . In the preparations of the right atrium obtained from the animals on the 60 th day, the rhythm was 4.39 ± 0.5 Hz. Thus, in our experiments, the greatest rhythm was observed on the 21 st day of postnatal development. Under the action of AP4A at a concentration of 10 μM in the preparations of the right atrium obtained from animals at the end of the first day and on the 14 th , 21
st , and 60 th days of life, the rhythm was 4.5 ± 0.9, 4.79 ± 1.0, 5.3 ± 0.6, and 3.67 ± 0.9 Hz, respectively. Thus, the AP4A did not affect the rhythm in the period from the end of the first day to the 21 st day of postnatal life but caused a statistically significant (p < 0.05, n = 6) decrease by the 60 th day, i.e., in the animals that we considered to be adults.
It was previously shown that ATP, a well-studied purine receptor agonist, increases the heart rhythm frequency in rats at various stages of postnatal development [19] . In contrast to ATP, AP4A reduces the rhythm generated by the heart pacemaker but only in adult animals. The obtained results allow us to make several assumptions: firstly, it is likely that the effects of ATP and AP4A are realized through various membrane receptors and intracellular signaling cascades. Secondly, it is likely that functional receptors mediating the effect of AP4A appear in the heart pacemaker only in the animals aged 60 days, unlike of that observed for ATP. Such differences may be due to the fact that there are different physiological roles of the two purine compounds in the regulation of the heart rhythm: the role of ATP can be reduced to maintaining the heart rhythm, while the function of AP4A (and possibly other APnA) may be to reduce the rhythm or limit the effect of excessive sympathetic stimulation on the rhythm in adult animals. At the next stage of the study, we investigated the role of P2-type receptors in mediating the effects of AP4A in the heart in early ontogeny. In our experiments, PPADS (the P2-receptor blocker) caused suppression of the effects of AP4A in the animals on the 21 st and 60 th days of postnatal development. Under the action of AP4A in the presence of 100 μM PPADS, DAP90% did not differ statistically from that observed when only PPADS was used in preparations of the left atrium (p > 0.1, n = 6; Fig. 3 ). However, in preparations obtained from animals at the end of the first day and on the 14 th day of life, PPADS did not inhibit a decrease in DAP90% caused by AP4A (p < 0.05, n = 6). Thus, in the rats aged 60 days (considered to be adults) and also in the rats on the 21 st day of life, the effects of AP4A are realized through purine P2-receptors.
It has been shown that purine P2-receptors appear in various tissues of mammals at the fetal stage of development [20] . In the perinatal period, P2Y2, P2Y4, and P2Y6 subtypes of purine receptors are found in various tissues [10, 21] . These subtypes of purine receptors are found in the myocardial tissue of the rat heart as well. It is well known that activation of P2Y-receptors can cause inhibitory effects in the cardiovascular system, including a decrease in myocardial contractility [11, 22] . In connection with the foregoing, we assume that suppression of the duration of AP caused by AP4A in young rats is due to activation of P2Y-receptors and is similar to that observed in adult animals. It remains unclear why the effects of AP4A persist in the presence of PPADS in rats from the end of the first day to the 14 th day of postnatal development. It can be assumed that this phenomenon is associated with reduced affinity of PPADS for purine receptors in newborn animals, which may have specific physicochemical properties, for example, due to heterodimerization with other receptors.
The obtained data suggest that AP4A causes a decrease in the duration of AP in the atrial and ventricular myocardium of rats at the early stages of postnatal ontogenesis. Thus, AP4A can influence the cardiac function for the period when sympathetic neural control is still lacking. The effect of AP4A is similar in magnitude in the rat atrial myocardium of all age groups studied, but the effect of AP4A in the ventricular myocardium was greater on the 21 st and 60 th days than on the first and 14 th days of postnatal ontogenesis. In other words, the effect of AP4A in the ventricular myocardium was greater during the particular period of ontogenesis, when sympathetic control of the cardiac function was forming. It can be assumed that the restriction of adrenergic stimulatory effects on the ventricular myocardium may be one of the physiological roles of AP4A.
